Literature DB >> 23983666

Intermittent hypoxia-induced renal antioxidants and oxidative damage in male mice: hormetic dose response.

Weixia Sun1, Xia Yin, Yuehui Wang, Yi Tan, Lu Cai, Bo Wang, Jun Cai, Yaowen Fu.   

Abstract

Obstructive sleep apnea causes cardiovascular disease via chronic intermittent hypoxia (IH), which may be related to oxidative stress. Nuclear factor-erythroid 2-related factor 2 (Nrf2) is an important cellular defense mechanism against oxidative stress by regulating its down-stream multiple antioxidants. The present study was to define whether IH can induce renal pathogenic damage and if so, whether Nrf2 and its down-stream antioxidants are involved in IH-induced pathogenic changes. Mice were culled for exposure to intermittent air as control or IH that consisted of 20.9% O2/ 8% O2 FIO2 alternation cycles (30 episodes per h) with 20 seconds at the nadir FIO2 for 12 h a day during daylight. Short-term IH exposure (3 - 7 days) induced significant increases in renal inflammatory response and antioxidant levels along with a reduction of the spontaneous content of malondialdehyde while long-term IH exposure (8 weeks) induced a significant decrease of antioxidant levels and significant increases of renal inflammation, oxidative damage, cell death, and fibrosis. This study suggests that IH induces a hormetic response, i.e.: short-term IH exposure is able to induce a protective response to protect the kidney from oxidative damage while long-term IH exposure is able to induce a damage effect on the kidney.

Entities:  

Keywords:  Intermittent hypoxia; Nrf2; kidney hypoxic damage; metallothionein

Year:  2012        PMID: 23983666      PMCID: PMC3748850          DOI: 10.2203/dose-response.12-027.Cai

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  35 in total

1.  Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes.

Authors:  Youichi Shinozaki; Schuichi Koizumi; Yasuo Ohno; Taku Nagao; Kazuhide Inoue
Journal:  Glia       Date:  2006-11-01       Impact factor: 7.452

2.  High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein.

Authors:  G Hartmann; M Tschöp; R Fischer; C Bidlingmaier; R Riepl; K Tschöp; H Hautmann; S Endres; M Toepfer
Journal:  Cytokine       Date:  2000-03       Impact factor: 3.861

3.  Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.

Authors:  Jianxun Wang; Ye Song; Laila Elsherif; Zhenyuan Song; Guihua Zhou; Sumanth D Prabhu; Jack T Saari; Lu Cai
Journal:  Circulation       Date:  2006-01-23       Impact factor: 29.690

4.  Chronic intermittent hypoxia induces thioredoxin system changes in a gender-specific fashion in mice.

Authors:  Qing Yun Li; Min Li; Yun Feng; Qian Guo; Shu Yi Gu; Jia Lin Liu; Rui Feng Zhang; Huan Ying Wan
Journal:  Am J Med Sci       Date:  2012-06       Impact factor: 2.378

5.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

6.  Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells.

Authors:  Srinivas Papaiahgari; Qin Zhang; Steven R Kleeberger; Hye-Youn Cho; Sekhar P Reddy
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

7.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Effect of age and hypoxia/reoxygenation on mRNA expression of antioxidative enzymes in rat liver and kidneys.

Authors:  R Martin; G Fitzl; C Mozet; H Martin; K Welt; E Wieland
Journal:  Exp Gerontol       Date:  2002-12       Impact factor: 4.032

Review 9.  Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease.

Authors:  Maurice Dematteis; Diane Godin-Ribuot; Claire Arnaud; Christophe Ribuot; Françoise Stanke-Labesque; Jean-Louis Pépin; Patrick Lévy
Journal:  ILAR J       Date:  2009

10.  Sleep-disordered breathing in nondialyzed patients with chronic renal failure.

Authors:  Nikolaos Markou; Maria Kanakaki; Pavlos Myrianthefs; Dimitrios Hadjiyanakos; Dimosthenis Vlassopoulos; Anastasios Damianos; Konstantinos Siamopoulos; Miltiadis Vasiliou; Stavros Konstantopoulos
Journal:  Lung       Date:  2006 Jan-Feb       Impact factor: 3.777

View more
  17 in total

1.  Obstructive Sleep Apnea, Other Sleep Characteristics, and Risk of CKD in the Atherosclerosis Risk in Communities Sleep Heart Health Study.

Authors:  Kelsie M Full; Chandra L Jackson; Casey M Rebholz; Kunihiro Matsushita; Pamela L Lutsey
Journal:  J Am Soc Nephrol       Date:  2020-06-26       Impact factor: 10.121

Review 2.  Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?

Authors:  Bisher Abuyassin; Kumar Sharma; Najib T Ayas; Ismail Laher
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

3.  Consider the Kidney when Managing Obstructive Sleep Apnea.

Authors:  Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

4.  Chronic intermittent hypoxia exposure induces kidney injury in growing rats.

Authors:  Neha-Devi Poonit; Yi-Chun Zhang; Chu-Yuan Ye; Hui-Lin Cai; Chen-Yi Yu; Ting Li; Xiao-Hong Cai
Journal:  Sleep Breath       Date:  2017-11-09       Impact factor: 2.816

5.  Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Chandra L Jackson; Chizoba Umesi; Symielle A Gaston; Ali Azarbarzin; Joseph Lunyera; John A McGrath; W Braxton Jackson Ii; Clarissa J Diamantidis; Ebony Boulware; Pamela L Lutsey; Susan Redline
Journal:  Thorax       Date:  2020-12-04       Impact factor: 9.139

6.  Intermittent hypoxia exacerbates increased blood pressure in rats with chronic kidney disease.

Authors:  Jennifer L Riggs; Carolyn E Pace; Heather H Ward; Laura V Gonzalez Bosc; Lynnette Rios; Adelaeda Barrera; Nancy L Kanagy
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-13

Review 7.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04

8.  Androgens modulate chronic intermittent hypoxia effects on brain and behavior.

Authors:  Brina Snyder; Phong Duong; Jenny Trieu; Rebecca L Cunningham
Journal:  Horm Behav       Date:  2018-10-06       Impact factor: 3.492

9.  Angiotensin-(1-7) relieved renal injury induced by chronic intermittent hypoxia in rats by reducing inflammation, oxidative stress and fibrosis.

Authors:  W Lu; J Kang; K Hu; S Tang; X Zhou; S Yu; L Xu
Journal:  Braz J Med Biol Res       Date:  2017-01-09       Impact factor: 2.590

10.  Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea.

Authors:  Bisher Abuyassin; Mohammad Badran; Najib T Ayas; Ismail Laher
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.